Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why is IPIX not trading in the multiple dollars with a magical unbelievably unprecedented miracle transformational multi use drug that will liberate the world from a multitude of afflictions.
Better get your booster to answer….
Mercks Covid 19 drug proven WORTHLESS in study. Not really shocking even after billions in sales. BP has become a money making sinister industry that hurts those they are supposed to help.
*B426*
F, A/S…The last sentence says it all. The second coming will happen before they do anything.
Hopefully IPIX can get out of that deal.
I agree. The stock price will dramatically increase in 2023. Good times coming.
*B426*
When the nasal spray is finally formulated IPIX will be trading 10, 20, 100s million shares a day.
We can anticipate the BP partnership soon after.
The Alfasigma contract needs to be terminated if they keep slow rolling their end of the deal.
Covid isn’t a excuse anymore. Pfizer and Moderna can produce new gene therapy shots every other week now. They used 8 blind mice for their latest trials.
At least *B426* can improve the eyesight of the mice before their next trial.
*B426*
It’s amazing how many institutions, researchers, scholars worldwide are now investigating *B426*. NIH, NIADS also involved in the studies. The more research papers published by the scientific community the better. It only enhances Bs future prospects.
It’s only a matter of time before *B426* is commercially viable for the first of potentially many ailments. The finished nebulizer / inhaler news will be a welcome addition to the ever growing acknowledgment of *B426*’s outstanding potential for a vast array of ailments.
I could see a government entity becoming involved financially with the commercialization of *B426* for the sake of its citizens if BP continues to stay on the sidelines.
Too many scholarly eyes of researchers at many worldwide institutions are involved now to hold back the inevitable success of *B426* at this point. Hoard as many shares as you can afford. Be like Kips Bay…
After reading that excellent analytic article NOW you know why there is such a ongoing attack against IPIX. Leo’s auction buy of *B426* will go down as one of the greatest purchases of all time and someone who hired this crew knows they made a major mistake not stepping up to the plate when they had the chance.
They want *B426* badly but the multiple scientific research teams analysis have upped the stakes in favor of IPIX.
It’s only a matter of time when someone silences the crew with a nice financial offer and they can move on.
I am asking for anyone who can show ANY OTC company that has its drug being essentially funded by the US Government that trades under 1 dollar. It has NOW been 1 day since I asked the question.
Let’s go to 2 dollars…
IPIX trading at 2 cents has a host of independent researchers funded by the US Government grants plus SEVERAL academic research groups that are working on the Government dime. Pretty intriguing for a little two penny stock.
The free government financed lab testing continues 2 years after a single academic entity at GMU showed the promise of *B426*. That GMU testing was funded by IPIX.
Now there are SEVERAL academic institutions plus groups of government funded researchers testing the capabilities of *B426*. Why the increased expansion of research if the drug showed no promise.
The detractors of IPIX should be able to name all the other companies trading at a dollar or below that is getting the same financial support by the government and multiple independent researchers. I doubt that we will see a answer to that question.
Just one breakthrough by any of the groups researching *B426* will focus the other researchers in a certain direction and the stock price will explode.
Antiviral, anti fungal, nebulizer, inhaler , WHO KNOWS.
So many avenues they could be exploring.
I like the fact that the educated scientific community has a steadily expanding group of eyeballs focusing on *B426*.
To those who have all the answers I will be waiting for the list of other tiny OTC companies under a dollar that has government and academic institutions paying the freight for testing of their drug.
Accumulation and accumulating..”B426”
100 % agree. Need a * B426* game changer announcement…
Kips Bay is probably adding to the 45 MILLION pile they have accumulated. I won’t be shocked they have over 50 -60 million stashed away now. They went from 21 million shares to 45 million shares in total silence.
BTW, congrats to them. A unbelievable wealth producer for them if expected positive events take place.
*B426*
I presume India is where that site is based. I am only fluent in Spanish as a second language but will try navigating that site.
*B426*
Nice find PJ. Very intriguing. I get a error database when I tried opening the link.
Hopefully there is something of significance between the 2 companies.
*B426*
A IPIX / MERCK collaboration should be in the making considering the recent testing results.
The impressive results that increases both drugs individually from 50% effectiveness to a combined 95% should have both companies talking together. LIKE YESTERDAY.
Merck recently paid 400 MILLION for a worthless one trick pony during the past year and they will never get that money back. *B426* should be on their radar at this point. If not shame on Leo. I have a hard time believing that major BPs not knowing about all testing associated with their drug and not having access to the results. Is Merck on the phone right now, SHOULD BE.
We will see.
*B426* , the inhaler / nebulizer
The revolutionary laser system will only compliment the soon to be approved wonder drug. Once one arm of *B426* gets FDA approval and commercialized the rest of Bs vast wealth of abilities will move much more rapidly through the process.
Too many World class individuals, researchers, scientists have worked, tested and signed their professional names to documented paperwork touting the potential of *B426* for the drug NOT TO BE SUCCESSFUL.
*B426* I will just keep accumulating shares. Also,
One day closer to nasal spray announcement.
*B426* I can’t say it enough,
Nasal spray soon…*B426*
Nice finds PJ007…*B426*
Great post RG2016..Sit back and let IPIX keep receiving all this free testing. A FDA approved nasal spray would give IPIX instant credibility and would allow the company to grow exponentially so they can explore all aspects of the drug.
By that time, the fungal, OM and other avenues of *B426* will be well established by the multitude of researchers that are in the testing process at this very moment.
They will make the next chapter of *B426* development much easier with all their charitable contributions and hard work giving a strong base of analysis to work from in the future.
*B426*
That’s the initial payment for research going to UCSF. *B426* is already being explored at that facility. How much of that 67 million will be used to refine *B426* for commercialization.
Hiring the great Dr Degrado was a brilliant move to move *B426* along.
It’s amazing how much free research is coming IPIXs way.
*B426*
GREAT POST….*B426*
One day closer to the *B426* inhaler. The safe alternative to a healthy life.
*B426*…
When it comes to *B426* safety I only believe the scientists who sign off on the results that they found in the labs.
Why on earth would I consider the opinions of any unknown keyboard researcher who wouldn’t know a test tube from a tire tube.
*B426*
It’s GREAT to see that the researchers found that *B426* is NON TOXIC but we already knew how super safe the wonder drug has been in other studies around the World.
Just more confirmation.
BTW, Astra Zeneca just spectacularly failed with their nasal spray trial.
*B426* inhaler moving along Everyday
You have to believe Merck is getting the same research info delivered to them about their drug being remarkably more effective when combined with *B426*.
I wonder if they have made inquiries about acquiring a batch of WONDER DRUG *B426* from Leo for the own testing.
They can turn their stand alone 50% effective multi million dollar drug into a 95% effective multi BILLION dollar by combining it with super safe *B426*.
They could corner the market.
*B426*
Merck spent 400 million on a basically worthless one trick pony from Ridgeback. What is a multi purpose super safe WONDER drug “*B426*” worth that have been proven to double the effectiveness of their own drug. They could now dominate a multi billion dollar market on that one therapy. That leaves them with a host of other multi billion afflictions that they can corner the market.
No wonder Kips Bay has loaded up with 45 Million shares.
*B426* will B HUGE…..
Love your Onion analogy. Absolutely Perfect description.
*B426*
What can’t wonder drug *B426* do at this point. Even the hard working 6 amigos know *B426* has the potential to be a life saving drug for a vast array of ailments.
The phrase “show me the money” is where I agree with the magnificent 6. It’s great that *B426* is exciting to the hordes of scientists and researchers but my baby needs a new pair of shoes. The bread bags aren’t good for the kids feet.
More research is always a good thing and should pay off big down the road. I hope I am still alive when it happens.
Congrats to Leo for moving *B426* forward on a shoestring budget.
Khosta-2, the new respiratory virus from Russian bats is CV19 vaccine resistant and monoclonal antibodies have also proven worthless in testing. Scientists don’t know what to do.
I guess Leo will be asked for another batch of *B426*.
Let’s get moving on that *B426* inhaler/nebulizer formula.
*B426*…
Was K being tested by RBLs, government scientists, and multiple institutions at this very moment. Were dozens, maybe 100s of researchers signing their names to official documents on the outstanding results of K. Were the government agency’s asking for more K product to expand their CONTINUING research into K.
Was K being examined for a array of afflictions at the same time by multiple entities.
Nobody in the last 3 years bought into IPIX for K.
Waste of time giving a crap about something most have long ago forgot about.
K didn’t make the cut. This was decided by the total lack of interest by researchers and scientists.
The OPPOSITE is true of *B426*. The research only continues to expand.
*B426* is showing extreme promise in multiple directions and that is exactly where IPIX should be focused.
If Leo can’t get something as promising as *B426* over the finish line then I will whole heartedly agree with the six amigos on his incompetence.
I don’t even care about the futuristic laser company that they have bought into. That’s way down the road.
*B426* is now…
More confirmation that *B426* HAS potential to be a blockbuster drug. With all the scientific studies from numerous entities proving that it can be beneficial with a multitude of afflictions there should be NO EXCUSES for Leo to fk this up. A MAJOR deal should be a gimme. Giving up K to focus on the new surgical laser system is OK in my book. K wasn’t going anywhere fast.
We should easily pass a 8 mouse trial like Pfizer had for the new booster trial. I believe we will fair better since their mice all caught Covid anyway and they still received FDA approval.
GO IPIX INHALER / NEBULIZER GO.
*B426* SAVE THE MICE FIRST then the populace…
*B426* …
So true…Great post…*B426*
I see that Basilea has multiple “internal and external” Innovation trials running right now. Using drugs Licensed from FCCDC. I believe IPIX gets 6% of any revenues generated from the FCCDC deal.
Basilea being a spin-off of Roche pharma has very deep pockets with a extensive research department.
Things hopefully move faster there than Alfasigma seems to be moving. The introduction of Covid sure didn’t help with the Alfasigma research moving fast.
Many, many irons starting to glow red and now government researchers working diligently on a inhaler/ nebulizer.
No wonder KIPS BAY has bought 45 MILLION shares.
*B426*
Thanks WTBW. It’s actually refreshing that knowledgeable scientific individuals have signed their names to their findings.
Trust those highly educated professionals that are openly transparent and not some unknown who is hiding in the shadows.
*B426* , the wait will be worth it…
The *B426* inhaler should be updated soon. Is Kips Bay investments still hoarding shares. Last growing total was 45million shares.
What are they expecting that has them giddy with the wallet.
*B426* a life saver in a inhaler…
I believe that the answer in fact is NO….
*B426* here comes the INHALER…